Inspire Medical Systems, Inc.
NYSE:INSP
192.71 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 624.799 | 407.856 | 233.394 | 115.381 | 82.05 | 50.593 | 28.567 | 16.427 | 8.012 |
| Cost of Revenue
| 96.576 | 66.115 | 33.279 | 17.623 | 13.643 | 10.056 | 6.018 | 3.905 | 2.809 |
| Gross Profit
| 528.223 | 341.741 | 200.115 | 97.758 | 68.407 | 40.537 | 22.549 | 12.522 | 5.203 |
| Gross Profit Ratio
| 0.845 | 0.838 | 0.857 | 0.847 | 0.834 | 0.801 | 0.789 | 0.762 | 0.649 |
| Reseach & Development Expenses
| 116.536 | 68.645 | 37.35 | 26.092 | 12.839 | 7.388 | 6.194 | 7.091 | 7.079 |
| General & Administrative Expenses
| 351.658 | 246.388 | 154.815 | 101.474 | 72.465 | 53.527 | 3.806 | 19.284 | 2.631 |
| Selling & Marketing Expenses
| 100.3 | 74.3 | 47.8 | 26.4 | 18 | 9.3 | 28.552 | 3.4 | 15.291 |
| SG&A
| 451.958 | 320.688 | 202.615 | 127.874 | 90.465 | 53.527 | 32.358 | 22.684 | 17.922 |
| Other Expenses
| -0.195 | -0.049 | -0.117 | 0.145 | 0.012 | -0.016 | 0.042 | -0.029 | -0.041 |
| Operating Expenses
| 568.494 | 389.333 | 239.965 | 153.966 | 103.304 | 60.915 | 38.552 | 29.775 | 25.001 |
| Operating Income
| -40.271 | -47.592 | -39.85 | -56.208 | -34.897 | -20.378 | -16.003 | -17.253 | -19.798 |
| Operating Income Ratio
| -0.064 | -0.117 | -0.171 | -0.487 | -0.425 | -0.403 | -0.56 | -1.05 | -2.471 |
| Total Other Income Expenses Net
| 20.365 | 3.324 | -2.12 | -0.88 | 1.694 | -0.016 | 0.042 | -0.029 | -0.041 |
| Income Before Tax
| -19.906 | -44.268 | -41.97 | -57.088 | -33.203 | -21.828 | -17.511 | -18.528 | -21.337 |
| Income Before Tax Ratio
| -0.032 | -0.109 | -0.18 | -0.495 | -0.405 | -0.431 | -0.613 | -1.128 | -2.663 |
| Income Tax Expense
| 1.247 | 0.613 | 0.072 | 0.115 | 0.04 | 1.854 | 1.795 | 1.274 | 1.523 |
| Net Income
| -21.153 | -44.881 | -42.042 | -57.203 | -33.243 | -21.828 | -17.511 | -18.528 | -21.337 |
| Net Income Ratio
| -0.034 | -0.11 | -0.18 | -0.496 | -0.405 | -0.431 | -0.613 | -1.128 | -2.663 |
| EPS
| -0.72 | -1.6 | -1.54 | -2.19 | -1.4 | -1.5 | -1.3 | -1.49 | -1.71 |
| EPS Diluted
| -0.72 | -1.6 | -1.54 | -2.19 | -1.4 | -1.5 | -1.3 | -1.49 | -1.71 |
| EBITDA
| -40.271 | -42.591 | -39.842 | -54.971 | -31.084 | -18.524 | -15.473 | -17.122 | -19.653 |
| EBITDA Ratio
| -0.064 | -0.104 | -0.171 | -0.476 | -0.379 | -0.366 | -0.542 | -1.042 | -2.453 |